Nicergoline tartrate

This classification denotes an alpha-adrenergic blocking agent C24H26BrN3O3.C6H10O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J7P36Z4900, chemically known as ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8.beta.)-, (2r,3r)-2,3-dihydroxybutanedioate (salt), but more generally known as nicergoline tartrate, which bears US NIH Compound Identifier 134961. European Medicines Agency schedules Nicergoline tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23254. Most nations, for tariff and trade purposes, schedule nicergoline tartrate under HS 29396900 and SITC 54146. As of Q4 2014, NICERGOLINE TARTRATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H]([C@@H](C)C(=O)O)C(=O)O.CN1CC2C3C1CCCC3[C@]4(C[C@H](CN([C@@H]4C2)C)COC(=O)C5CC(CNC5)BR)OC.